Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $413,578 were sold by Kulkarni Samarth on Mar 21 ’25. At $41.23 per share, Kulkarni Samarth sold 10,031 shares. The insider’s holdings dropped to 195,085 shares worth approximately $7.42 million following the completion of this transaction.
Also, Bruno Julianne sold 1,714 shares, netting a total of over 70,668 in proceeds. Following the sale of shares at $41.23 each, the insider now holds 10,544 shares.
Before that, Prasad Raju had sold 2,197 shares from its account. In a trade valued at $90,582, the Chief Financial Officer traded CRISPR Therapeutics AG shares for $41.23 each. Upon closing the transaction, the insider’s holdings decreased to 2,197 shares, worth approximately $0.64 million.
As published in a research note from Evercore ISI on February 14, 2025, CRISPR Therapeutics AG [CRSP] has been rated up from an In-line to an Outperform and the price target has been revised to $99 from $60. Analysts at TD Cowen upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in mid February. As of February 03, 2025, H.C. Wainwright has initiated its “Buy” rating for CRSP. Earlier on August 06, 2024, Needham resumed its rating. Their recommendation was “a Buy” for CRSP stock.
Analyzing CRSP Stock Performance
During the last five days, there has been a drop of approximately -7.60%. Over the course of the year, CRISPR Therapeutics AG shares have dropped approximately -3.35%. Shares of the company reached a 52-week high of $55.88 on 02/19/25 and a 52-week low of $36.52 on 01/13/25. A 50-day SMA is recorded $42.95, while a 200-day SMA reached $47.88.
Support And Resistance Levels for CRISPR Therapeutics AG (CRSP)
According to the 24-hour chart, there is a support level at 37.50, which, if violated, would cause prices to drop to 36.96. In the upper region, resistance lies at 38.93. The next price resistance is at 39.82. RSI (Relative Strength Index) is 36.58 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.21, which suggests the price will decrease in the coming days. Percent R is at 97.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
